Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 5,500 shares at $86.24 ($458K) on 2018-11-09, disclosed to the SEC on 2018-11-14.
Scheduled sale ($458k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.08 | 2,757 | $226K | 49.4% |
| 2 | $83.25 | 1,006 | $84K | 18.3% |
| 3 | $84.45 | 735 | $62K | 13.6% |
| 4 | $85.26 | 902 | $77K | 16.8% |
| 5 | $86.24 | 100 | $9K | 1.9% |
| Total | $83.21 avg | 5,500 |
| $458K |
| 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |